Imexpharm Revenue

Imexpharm had revenue of 594.06B VND in the quarter ending March 31, 2025, with 20.96% growth. This brings the company's revenue in the last twelve months to 2.31T, up 15.07% year-over-year. In the year 2024, Imexpharm had annual revenue of 2.21T with 10.59% growth.

Revenue (ttm)

2,308.08B

Revenue Growth

+15.07%

P/S Ratio

3.28

Revenue / Employee

1.60B

Employees

1,452

Market Cap

7,577.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2,205.12B	211.08B	10.59%
Dec 31, 2023	1,994.04B	350.33B	21.31%
Dec 31, 2022	1,643.71B	377.11B	29.77%
Dec 31, 2021	1,266.60B	-102.83B	-7.51%
Dec 31, 2020	1,369.42B	-33.03B	-2.36%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Joint Stock Commercial Bank for Foreign Trade of Vietnam	66.07T
Vingroup JSC	251.38T
Joint Stock Commercial Bank for Investment and Development of Vietnam	60.49T
Vinhomes JSC	109.81T
Vietnam Joint Stock Commercial Bank for Industry and Trade	55.63T
Vietnam Technological and Commercial Joint Stock Bank	42.38T
FPT Corporation	64.81T
Hoa Phat Group JSC	145.62T

Revenue Rankings